Editor's Picks

Gainers Trends: Nexalin, Armada, Roze AI, Mattel, Accenture

 
Nexalin Technology (NASDAQ: NXL) rose 76.4% to $7.55 on about 61.5 million shares after a 10-year exclusive distribution and manufacturing deal with Inovanexa covering seven South American countries and an initial 100-device program for its ANVISA-approved Nexalin Sync.
 
Armada Acquisition Corp. II (NASDAQ: XRPN) gained 42.9% to $23.43 after shareholders approved its merger with Evernorth. The deal is expected to bring about $300 million in cash and roughly 473 million XRP, with closing planned for October 7 and Nasdaq trading under XRPN on October 8.
 
Roze AI (NASDAQ: RZAI) advanced 20.2% to $26.31 on about 17 times normal volume. The newly listed developer of AI-based fire forecasting had no fresh announcement.
 
Mattel (NASDAQ: MAT) rose 18.8% to $15.04 after a report that Authentic Brands Group discussed a takeover above $20 a share. A day earlier, Mattel named Roger Lynch its next CEO.
 
Accenture (NYSE: ACN) gained 15.8% to $212.30 after a fourth-quarter beat and fiscal 2027 sales guidance of 3%–6% growth.

Leave a comment

Your email address will not be published. Required fields are marked *